This study demonstrates that osteocyte-derived conditioned medium, when LRP5 is overexpressed, not only directly restrains tumor cell aggressiveness but also reprograms the “soil” of the bone microenvironment, thereby achieving multi-faceted therapeutic benefits. The gene discussed is LRP5; the disease is neoplasm.